SCHEMBL14725971

SCHEMBL14725971

NNc1ncc(Br)nc1N1CCOCC1

nearest known ligand 0.44

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.44
MAPK1 P28482 1/20 0.44
TSHR P16473 1/20 0.43
KDM4E B2RXH2 2/20 0.43
GAA P10253 1/20 0.43
POLB P06746 1/20 0.39
IGF1R P08069 2/20 0.39
JAK3 P52333 1/20 0.38
LRRK2 Q5S007 2/20 0.38
ABL1 P00519 1/20 0.37
BCR P11274 1/20 0.37
PIK3CA P42336 8/20 0.37
PIK3CD O00329 2/20 0.37
PIK3CB P42338 1/20 0.37
MTOR P42345 3/20 0.36
PIK3CG P48736 1/20 0.36
PIK3R1 P27986 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30366458 0.81 KDM4E (0.51) ALDH1A1MAPK1TSHRKDM4EGAA
SCHEMBL1445139 0.81 KDM4E (0.51) ALDH1A1MAPK1TSHRKDM4EGAA
SCHEMBL14725974 0.76 ALDH1A1 (0.48) ALDH1A1MAPK1TSHRKDM4EGAA
SCHEMBL11219511 0.76 ALDH1A1 (0.48) ALDH1A1MAPK1TSHRKDM4EGAA
SCHEMBL2321391 0.76 MAPK1 (0.50) ALDH1A1MAPK1TSHRKDM4EGAA
SCHEMBL14667180 0.71 PIK3CA (0.39) ALDH1A1MAPK1TSHRKDM4EGAA
SCHEMBL11232604 0.70 ALDH1A1 (0.44) ALDH1A1MAPK1TSHRKDM4EGAA
SCHEMBL2321570 0.69 ROCK2 (0.63) ALDH1A1MAPK1TSHRPOLB
SCHEMBL31128249 0.68 POLB (0.47) ALDH1A1MAPK1TSHRKDM4EGAA
SCHEMBL28610329 0.68 IGF1R (0.57) MAPK1TSHRKDM4EPOLBIGF1R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9073927-B2 Inhibitors of PI3 kinase FUNDACION CENTRO NACIONAL DE INVESTIGACIONES ONCOLOGICAS CARLOS III (ES) 2015-07-07 US disclosed
US-9073927-B2 Inhibitors of PI3 kinase FUNDACION CENTRO NACIONAL DE INVESTIGACIONES ONCOLOGICAS CARLOS III (ES) 2015-07-07 US disclosed
US-20130053371-A1 INHIBITORS OF PI3 KINASE CENTRO NACIONAL DE INVESTIGACIONES ONCOLÓGICAS (CNIO) (ES) 2013-02-28 US disclosed
US-20130053371-A1 INHIBITORS OF PI3 KINASE CENTRO NACIONAL DE INVESTIGACIONES ONCOLÓGICAS (CNIO) (ES) 2013-02-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130053371-A1 INHIBITORS OF PI3 KINASE PIK3CA, MTOR, PIK3C2A ALDH1A1 2425/4885MAPK1 138/4885TSHR 2962/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.